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Introduction
Immune-mediated pathogenesis has been suggested for
idiopathic sensorineural hearing loss (iSNHL). Recent
studies have investigated the relationship between
iSNHL and autoantibodies against inner ear antigens,
but specific tests are not available.
Objectives
To assess the positivity of autoantibodies against inner ear
in a series of pediatric patients with idiopathic sensori-
neural hearing loss.
Methods
We conducted a prospective, non-interventional observa-
tional study in a series of pediatric patients affected with
iSNHL. Autoantibodies against inner ear (anti-Cogan
peptide, anti-connexin 26, anti-DEP1/CD148 and anti-
reovirus), previously described in the serum of patients
with Cogan’s syndrome, were detected in our populations.
The characteristics of children who resulted positive were
also evaluated to verify if clinical data, disease progression
and response to treatment could confirm an immune-
mediated pathogenesis.
Results
Eleven patients were enrolled and 9 of them resulted
positive for the inner ear antibodies detected. Non-organ
specific autoantibodies were present in 5 children out of
9. An immune-mediated condition was diagnosed in 2
cases and minor immune manifestations were found in
other 2 patients. In 5 cases hearing loss remained stable
with no therapy, otherwise 4 children developed hearing
loss progression. Two subjects were treated with steroids
and methotrexate achieving hearing improvement.
Another subject started methotrexate treatment showing
hearing loss stabilization.
Conclusion
Most of clinical characteristics and comorbidities
described, added to immunologic tests results and to treat-
ment efficacy, suggest an immune-mediated pathogenesis
of hearing loss. Inner ear autoantibodies are not able to
identify children affected with autoimmune sensorineural
hearing loss but, integrated with clinical data, they can
represent a diagnostic aid for the physician. Large prospec-
tive studies are needed to investigate usefulness, diagnostic
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